Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up.

Wang YC, Yang CC, Bai YM, Kuo TB.

Neuropsychobiology. 2008;57(4):200-5. doi: 10.1159/000149818. Epub 2008 Aug 5.

PMID:
18679039
2.

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Mortimer A, Martin S, Lôo H, Peuskens J; SOLIANOL Sudy Group.

Int Clin Psychopharmacol. 2004 Mar;19(2):63-9.

PMID:
15076013
3.

Amisulpride for schizophrenia.

Mota NE, Lima MS, Soares BG.

Cochrane Database Syst Rev. 2002;(2):CD001357. Review.

PMID:
12076408
4.

A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.

Martin S, Lĵo H, Peuskens J, Thirumalai S, Giudicelli A, Fleurot O, Rein W; SOLIANOL Study Group.

Curr Med Res Opin. 2002;18(6):355-62.

PMID:
12442883
5.

Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.

Peuskens J, De Hert M, Mortimer A; SOLIANOL Study Group.

Int Clin Psychopharmacol. 2007 May;22(3):145-52.

PMID:
17414740
7.

Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.

Molina JD, Toledo-Romero F, López-Rodríguez E, Amorin-Díaz M, Lerma-Carrillo I, López-Muñoz F.

Pharmacopsychiatry. 2011 Jun;44(4):142-7. doi: 10.1055/s-0031-1279728. Epub 2011 Jun 27.

PMID:
21710404
8.

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.

Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, Klieser E.

J Clin Psychopharmacol. 2001 Feb;21(1):8-13.

PMID:
11199953
9.

Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.

Quednow BB, Wagner M, Westheide J, Beckmann K, Bliesener N, Maier W, Kühn KU.

Biol Psychiatry. 2006 Mar 15;59(6):536-45. Epub 2005 Sep 1.

PMID:
16139819
10.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
11.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
12.

Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.

Hofer A, Rettenbacher MA, Edlinger M, Huber R, Bodner T, Kemmler G, Sachs G, Fleischhacker WW.

Pharmacopsychiatry. 2007 Jan;40(1):1-8.

PMID:
17327953
13.

[Heart rate variability in schizophrenic patients treated with antipsychotic agents].

Cohen H, Loewenthal U, Matar M, Kotler M.

Harefuah. 2001 Dec;140(12):1142-7, 1231. Hebrew.

PMID:
11789296
14.
15.

Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy.

Lerner V, Bergman J, Borokhov A, Loewenthal U, Miodownik C.

Clin Neuropharmacol. 2005 Mar-Apr;28(2):66-71.

PMID:
15795548
16.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
17.

Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.

Molina JD, Lerma-Carrillo I, Leonor M, Pascual F, Blasco-Fontecilla H, González-Parra S, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):10-5. doi: 10.1097/WNF.0B013E3181672213.

PMID:
18978498
18.

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

Leucht S, Pitschel-Walz G, Engel RR, Kissling W.

Am J Psychiatry. 2002 Feb;159(2):180-90.

PMID:
11823257
19.

Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.

Wagner M, Quednow BB, Westheide J, Schlaepfer TE, Maier W, Kühn KU.

Neuropsychopharmacology. 2005 Feb;30(2):381-90.

20.

Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.

Zink M, Henn FA, Thome J.

Eur Psychiatry. 2004 Feb;19(1):56-8.

PMID:
14969782

Supplemental Content

Support Center